https://www.scienceboard.net/index.aspx?sec=log&itemID=5100
0
0
36 words
0
Comments
A new drug neutralizes SARS-CoV-2 and its variants by acting as an ACE2 receptor decoy, Dana-Farber Cancer Institute researchers revealed.
You are the first to view
Create an account or login to join the discussion